T Scientific KRX:057680KOSDAQ
티사이언티픽 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11
In Q2 2026, T Scientific reported revenue of ₩7.0bn, down 15.0% year on year, and an operating loss of ₩536m. T Scientific (티사이언티픽) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Sep 15 with 1 article.
T Scientific quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩7.0bn | -15.0% | −₩536m | −₩677m |
| Q1 2026 | ₩6.2bn | -12.4% | −₩1.0bn | −₩1.0bn |
| Q4 2025 derived | ₩12.8bn | -20.6% | ₩1.2bn | ₩254m |
| Q3 2025 | ₩8.5bn | -2.9% | −₩51m | ₩95m |
| Q2 2025 | ₩8.3bn | -7.6% | ₩40m | ₩1.6bn |
| Q1 2025 | ₩7.0bn | -23.7% | −₩888m | −₩3.5bn |
| Q4 2024 derived | ₩16.1bn | +50.8% | −₩8.6bn | ₩1.7bn |
| Q3 2024 | ₩8.7bn | +45.7% | −₩845m | −₩4.4bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
T Scientific top stories 2 weeks, by number of outlets
- 1
